Rocket Pharmaceuticals, Inc.

RCKT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001281895

SEC filings (opens in a new tab)

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of RCKT: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	164	1	175	+12
Shares	76.4M	11.7K	89.4M	+13.1M (+17.1%)
Value	$1.52B	$232.7K	$1.83B	+$314.9M (+20.8%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to RCKT in Q3 2023
Institution	Shares	Value	% of portfolio
Frazier Life Sciences Management, L.P.	1,403,013	$28.7M	1.91%
Avoro Capital Advisors LLC	1,250,000	$25.6M	0.40%
Ikarian Capital, LLC	654,726	$13.4M	4.98%
Comerica Bank	440,076	$9.02M	0.05%
Tang Capital Management LLC	150,000	$3.07M	0.43%
Blair William & Co	149,789	$3.07M	0.01%
Boothbay Fund Management, LLC	132,192	$2.71M	0.10%
Simplex Trading, LLC	101,928	$2.09M	0.08%
Thrivent Financial for Lutherans	82,214	$1.68M	0.00%
SG Americas Securities, LLC	81,947	$1.68M	0.02%
Caption Management, LLC	75,000	$1.54M	0.20%
Moody Aldrich Partners LLC	58,027	$1.19M	0.23%
Jump Financial, LLC	39,463	$808.6K	0.03%
Balyasny Asset Management LLC	34,205	$700.9K	0.00%
Rathbone Brothers plc	30,000	$614.7K	0.00%
Nebula Research & Development LLC	21,435	$439.2K	0.23%
Yarbrough Capital, LLC	19,531	$400.2K	0.02%
Pier 88 Investment Partners LLC	18,000	$368.8K	0.09%
Jefferies Financial Group Inc.	17,155	$351.5K	0.01%
VELA Investment Management, LLC	16,079	$329.5K	0.14%
Los Angeles Capital Management LLC	13,980	$286.4K	0.00%
Voloridge Investment Management, LLC	11,269	$230.9K	0.00%
SEI Investments Co	9,798	$200.8K	0.00%
Annandale Capital, LLC	3,220	$66.0K	0.02%
Bank of Montreal	1,010	$23.8K	0.00%
Quantbot Technologies LP	1,000	$20.5K	0.00%
NBC Securities, Inc.	437	$8.00K	0.00%
Allworth Financial LP	6	$123	0.00%
Farther Finance Advisors, LLC	5	$102	0.00%

Sold out (17)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of RCKT in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Lord, Abbett & Co. LLC	1,197,182	$23.8M
PFM Health Sciences, LP	238,762	$4.74M
Ghost Tree Capital, LLC	75,000	$1.49M
Bellevue Group AG	55,600	$1.10M
D. E. Shaw & Co., Inc.	42,215	$838.8K
First Republic Investment Management, Inc.	36,530	$725.9K
ExodusPoint Capital Management, LP	34,798	$691.0K
Kiwi Wealth Investments Limited Partnership	26,734	$531.0K
Tudor Investment Corp Et Al	22,873	$454.5K
Cornerstone Advisory, LLC	18,000	$357.7K
Virtu Financial LLC	14,435	$287.0K
Y-Intercept (Hong Kong) Ltd	14,089	$279.9K
NinePointTwo Capital	11,936	$237.0K
Prudential Financial Inc	15,575	$225.1K
Occudo Quantitative Strategies LP	10,702	$212.6K
Aquatic Capital Management LLC	2,000	$40.0K
Wolverine Asset Management LLC	399	$7.93K

Not filed for Q3 2023 yet (1)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Efg Capital International Corp.	11,711	$232.7K